Skip to main navigation Skip to search Skip to main content

Technical recommendations for analyzing oxylipins by liquid chromatography-mass spectrometry

  • Nils Helge Schebb*
  • , Nadja Kampschulte
  • , Gerhard Hagn
  • , Kathrin Plitzko
  • , Sven W. Meckelmann
  • , Soumita Ghosh
  • , Robin Joshi
  • , Julia Kuligowski
  • , Dajana Vuckovic
  • , Marina T. Botana
  • , Ángel Sánchez-Illana
  • , Fereshteh Zandkarimi
  • , Aditi Das
  • , Jun Yang
  • , Louis Schmidt
  • , Antonio Checa
  • , Helen M. Roche
  • , Aaron M. Armando
  • , Matthew L. Edin
  • , Fred B. Lih
  • Juan J. Aristizabal-Henao, Sayuri Miyamoto, Francesca Giuffrida, Arieh Moussaieff, Rosário Domingues, Michael Rothe, Christine Hinz, Ujjalkumar Subhash Das, Katharina M. Rund, Ameer Y. Taha, Robert K. Hofstetter, Markus Werner, Oliver Werz, Astrid S. Kahnt, Justine Bertrand-Michel, Pauline Le Faouder, Robert Gurke, Dominique Thomas, Federico Torta, Ivana Milic, Irundika H.K. Dias, Corinne M. Spickett, Denise Biagini, Tommaso Lomonaco, Helena Idborg, Jun Yan Liu, Maria Fedorova, David A. Ford, Anne Barden, Trevor A. Mori, Paul D. Kennedy, Kirk Maxey, Julijana Ivanisevic, Hector Gallart-Ayala, Cécile Gladine, Markus Wenk, Jean Marie Galano, Thierry Durand, Ken D. Stark, Coral Barbas, Ulrike Garscha, Stacy L. Gelhaus, Uta Ceglarek, Nicolas Flamand, Julian L. Griffin, Robert Ahrends, Makoto Arita, Darryl C. Zeldin, Francisco J. Schopfer, Oswald Quehenberger, Randall Julian, Anna Nicolaou, Ian A. Blair, Michael P. Murphy, Bruce D. Hammock, Bruce Freeman, Gerhard Liebisch, Charles N. Serhan, Harald C. Köfeler, Per Johan Jakobsson, Dieter Steinhilber, Michael H. Gelb, Michal Holčapek, Ruth Andrew, Martin Giera, Garret A. FitzGerald, Robert C. Murphy, John W. Newman, Edward A. Dennis, Kim Ekroos, Ginger L. Milne, Miguel A. Gijón, Hubert W. Vesper, Craig E. Wheelock, Valerie B. O'Donnell
*Corresponding author for this work
  • University of Wuppertal
  • Karolinska Institutet
  • University of Duisburg-Essen
  • University of Pennsylvania
  • University of Valencia
  • Concordia University
  • Victoria University of Wellington
  • Columbia University
  • Georgia Institute of Technology
  • University of California at Davis
  • University of Greifswald
  • University College Dublin
  • Queen's University Belfast
  • University of California at San Diego
  • National Institutes of Health
  • BPG Bio
  • Universidade de São Paulo
  • Nestle
  • Hebrew University of Jerusalem
  • University of Aveiro
  • Lipidomix GmbH
  • Shimadzu
  • Friedrich Schiller University Jena
  • Goethe University Frankfurt
  • Université de Toulouse
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
  • Fraunhofer Cluster of Excellence of Immune Mediate Diseases CIMD
  • Duke-NUS Graduate Medical School
  • National University of Singapore
  • Aston University
  • University of Pisa
  • Chongqing Medical University
  • Technische Universität Dresden
  • Saint Louis University
  • University of Western Australia
  • Cayman Chemical
  • University of Lausanne
  • INRAE
  • Hamad bin Khalifa University
  • Institut des Biomolécules Max Mousseron
  • University of Waterloo
  • CEU Universities
  • University of Pittsburgh
  • Leipzig University
  • Université Laval
  • University of Vienna
  • RIKEN
  • Indigo BioAutomation
  • University of Manchester
  • University of Cambridge
  • University of Regensburg
  • Harvard University
  • Medical University of Graz
  • University of Washington
  • University of Pardubice
  • University of Edinburgh
  • Leiden University
  • University of Colorado Anschutz Medical Campus
  • Lipidomics Consulting Ltd.
  • Vanderbilt University
  • Centers for Disease Control and Prevention
  • Cardiff University

Research output: Contribution to journal › Article › peer-review

Abstract

Several oxylipins are potent lipid mediators that regulate diverse aspects of health and disease and whose quantitative analysis by liquid chromatography-mass spectrometry (LC-MS) presents substantial technical challenges. As members of the lipidomics community, we developed technical recommendations to ensure best practices when quantifying oxylipins by LC-MS.

Original languageEnglish
Article numbereadw1245
JournalScience Signaling
Volume18
Issue number887
DOIs
Publication statusPublished - 20 May 2025

Funding

The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention or the Agency for Toxic Substances and Disease Registry. Use of trade names is for identification only and does not imply endorsement by the Centers for Disease Control and Prevention, the Public Health Service, or the US Department of Health and Human Services. We gratefully acknowledge the following funding sources: LIPID MAPS (MRC MR/Y000064/1 to V.B.O.), US National Institutes of Health (R01 GM125944 to F.J.S.; R01 HL132550, P01 HL103455, and R33 HL157069 to B.F.; S10 OD23402 and S10 OD032141 to S.L.G.; U54 NS127758 to B.D.H.; R35 GM139641 to E.A.D.; and R21 AG081823 to G.L.M.), US National Institute of Environmental Health Sciences (Z01 ES025034 to D.Z. and R35 ES030443-01 and P42 ES004699 to B.D.H.), US Department of Agriculture (2032-51530-025-00D to J.W.N.), Medical Research Council (MR/Y000064/1 to V.B.O., MC_UU_00028/4 to M.P.M., and BB/W018322/1 to R.D.), European Union (ERC Adv grant no. 101095860 to M.H., CA19105 to M.F. and R.D., and 847419 to C.S.), Wellcome Trust (220257/Z/20/Z to M.P.M.), German Research Foundation (SCHE 1801 to N.H.S.; FE 1236/5-1 and FE 1236/8-1 to M.F. and SFB 1039/Z01 to R.G. and D.T.), German Federal Ministry of Education and Research (BMBF 031L0315A, DEEP_HCC and 01EJ2205A, and FERROPath to M.F.), São Paulo Research Foundation (FAPESP #2013/07937-8 to S.M.), Carlos III Health Institute (CP21II/00003 to J.K.), Ministerio de Ciencia, Innovación y Universidades/Agencia Estatal de Investigación/10.13039/501100011033 and the European Union NextGenerationEU/Plan de Recuperación, Transformación, y Resiliencia (JDC2022-049354-I to A.S.-I.), Natural Sciences and Engineering Research Council of Canada (RGPIN-2021-03777 to N.F.), the Portuguese Centre for the Environment and Marine Studies CESAM (UIDB/50017/2020, UIDP/50017/2020, and LA/P/0094/2020 to R.D.), and the Alzheimer's Association (AARGD-22-926459 to I.D.). Acknowledgments: The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the centers for Disease control and Prevention or the agency for Toxic Substances and Disease Registry. use of trade names is for identification only and does not imply endorsement by the centers for Disease control and Prevention, the Public Health Service, or the uS Department of Health and Human Services. Funding: We gratefully acknowledge the following funding sources: liPiD MaPS (MRc MR/Y000064/1 to V.B.o.), uS national institutes of Health (R01 gM125944 to F.J.S.; R01 Hl132550, P01 Hl103455, and R33 Hl157069 to B.F.; S10 oD23402 and S10 oD032141 to S.l.g.; u54 nS127758 to B.D.H.; R35 gM139641 to e.a.D.; and R21 ag081823 to g.l.M.), uS national institute of environmental Health Sciences (Z01 eS025034 to D.Z. and R35 eS030443-01 and P42 eS004699 to B.D.H.), uS Department of agriculture (2032-51530-025-00D to J.W.n.), Medical Research council (MR/ Y000064/1 to V.B.o., Mc_uu_00028/4 to M.P.M., and BB/ W018322/1 to R.D.), european union (eRc adv grant no. 101095860 to M.H., ca19105 to M.F. and R.D., and 847419 to c.S.), Wellcome Trust (220257/Z/20/Z to M.P.M.), german Research Foundation (ScHe 1801 to n.H.S.; Fe 1236/5-1 and Fe 1236/8-1 to M.F. and SFB 1039/Z01 to R.g. and D.T.), german Federal Ministry of education and Research (BMBF 031l0315a, DeeP_Hcc and 01eJ2205a, and FeRRoPath to M.F.), São Paulo Research Foundation (FaPeSP #2013/07937-8 to S.M.), carlos iii Health institute (cP21ii/00003 to J.K.), Ministerio de ciencia, innovación y universidades/agencia estatal de investigación/10.13039/501100011033 and the european union nextgenerationeu/Plan de Recuperación, Transformación, y Resiliencia (JDc2022-049354-i to a.S.-i.), natural Sciences and engineering Research council of canada (RgPin-2021-03777 to n.F.), the Portuguese centre for the environment and Marine Studies ceSaM (uiDB/50017/2020, uiDP/50017/2020, and la/P/0094/2020 to R.D.), and the alzheimer’s association (aaRgD-22-926459 to i.D.). Competing interests: V.B.o. is a consultant for Metasight. B.D.H. is a founder of eicosis Human Health with a potential pharmaceutical in clinical trials whose action depends on altering the profile of inflammatory lipids. K.M. is president and ceo of cayman chemical and a supplier of lipid standards. M.g. is a cofounder of the company enfanos llc. B.F. acknowledges a financial interest in creegh Pharmaceuticals, inc. e.a. Dennis is a cofounder of liponexus, inc. B.F. acknowledges an interest in creegh Pharmaceuticals, inc. K.e. is the owner of lipidomics consulting ltd. n.H.S., K.e., g.l.M., M.a.g., H.W.V., c.e.W., and V.B.o. are members of the international lipidomics Society oxylipin interest group.

FundersFunder number
Bundesministerium für Bildung und Forschung01eJ2205a, 031l0315a
Fundação de Amparo à Pesquisa do Estado de São Paulo2013/07937-8
University of OxfordZ01 eS025034, ES030443-01, P42 eS004699
NextGenerationEUJDC2022-049354-I
Wellcome Trust220257/Z/20/Z
Medical Research CouncilBB/ W018322/1, MC_UU_00028/4, MR/Y000064/1
Natural Sciences and Engineering Research Council of CanadaRGPIN-2021-03777
U.S. Department of Agriculture2032-51530-025-00D
Ministerio de Ciencia, Innovación y Universidades/Agencia Estatal de Investigación/10.13039/501100011033
Instituto de Salud Carlos IIIcP21ii/00003
European Research CouncilCA19105, 101095860
Deutsche ForschungsgemeinschaftScHe 1801, Fe 1236/8-1, FE 1236/5-1, SFB 1039/Z01
National Institutes of HealthP01 Hl103455, R21 ag081823, U54 NS127758, S10 oD23402, S10 oD032141, R01 gM125944, R35 GM139641, R01 Hl132550, R33 Hl157069
Portuguese Centre for the Environment and Marine Studies CESAMLA/P/0094/2020, UIDB/50017/2020, UIDP/50017/2020
National Alzheimer's AssociationAARGD-22-926459

    Keywords

    • Oxylipins/analysis
    • Chromatography, Liquid/methods
    • Mass Spectrometry/methods
    • Humans
    • Lipidomics/methods
    • Animals
    • Liquid Chromatography-Mass Spectrometry

    Fingerprint

    Dive into the research topics of 'Technical recommendations for analyzing oxylipins by liquid chromatography-mass spectrometry'. Together they form a unique fingerprint.

    Cite this